Comparison between wild type and mutated glycoprotein hormone receptors (GPHRs) TSHR, FSHR and LHCGR is established to identify determinants involved in molecular activation mechanism. The basic aims of current work are the discrimination of receptor phenotypes according the differences between activity states they represent and hit-assignment of classified phenotypes to 3D-structural positions to reveal functional-structural hotspots and interrelations between determinants that are responsible for corresponding activity states. Since it is hard to survey the vast amount of pathogenic and site-directed mutations at GPHRs and to improve an almost isolated consideration of individual point mutations, we present a system for systematic and diversified sequence-structure-function analysis (SSFA) (http://www.fmp-berlin.de/ssfa). In order to combine all mutagenesis data into one set, we converted the functional data into unified scaled values. This at least enables their comparison in a rough classification manner. In this study we describe the compiled data set and a wide spectrum 3
Introduction
The thyrotropin receptor (TSHR), follitropin receptor (FSHR) and lutropin (LH)-chorionic gonadotropin (CG) receptor (LHCGR) belong to the family of glycoprotein hormone receptors (GPHRs). These receptors are members of the seven transmembrane receptors (7TMRs) and they are evolutionary classified as rhodopsin-like receptors of family A. The thyroid-stimulating hormone (TSH) regulates growth and function of thyroid follicular cells and the gonadotropins LH/CG and follicle-stimulating hormone (FSH) play an important role in human reproduction (1; 2; 3; 4).
Therefore this class of receptors is central to medical, pharmaceutical, and biological research.
Investigating relationships between structure and function based on analysis and comparison of mutant phenotypes is a useful strategy to identify epitopes or cores of high functional importance (5) . This information is a prerequisite for understanding molecular mechanisms like signal initiation, intramolecular signal triggering and transmission, intermolecular signal transduction to the G-protein subtypes, as well as molecular reasons for dysfunctions occurring in mutation-related diseases (6; 7).
Much of pathogenic and site-directed mutation data on GPHRs has been published as functional effects of mutant phenotypes. Several reviews have considered one or two GPHRs (8; 9; 10; 11; 12; 13), but rarely all three GPHR subtypes together (7) . The large body of functional data is only poorly exploited for structure-function considerations of GPHR.
The major aims of our collection of receptor phenotypes and the developed bioinformatics tools were to provide a basis for: i. phenotype analysis by extraction and linking of functional with spatial specificities to reveal concealed structure-function relationships, ii. mapping of interrelations between sequence, structure and functions, and visualization of functional similarities and differences between GPHRs at certain sequence positions and structural loci, iii. contributing to new hypotheses concerning intramolecular interrelations and molecular signalling mechanisms, iv. evaluating data availability (or lack of information).
Faced with the options of either completely abandoning a wealth of functional data or enabling at least a rough data comparison, we converted the functional data into classifiable unified values. The functional data (cell surface expression level, maximum of hormone binding capability, basal and hormone induced Gαs/Gαq mediated signalling) are expressed as percentages of the corresponding 4 wild type-values (= 100%) for each experiment. We implemented a filtering and analyzing strategy which filters functional significance by user-specified queries or query combinations. Therefore, our semi-quantitative tool is designed to consider the functional data in rough distant values and by a twoclass separation mode. To improve the data management information concerning structural locations (2D and 3D), experimental conditions, and corresponding positions at homologous GPHRs is also provided and searchable. Our SSFA tool allows the comparison and analysis of functionalities from pathogenic and site directed mutations of TSHR, LHCGR and FSHR. Using our collated data set we give examples for SSFA usage by comparing and extracting signalling pathway-specific determinants of all three GPHR sub-classes.
Results and Discussion

SSFA concept and modules
Experimentally identified inactivating and constitutive activating mutations of GPHRs provide clues about the involvement of particular residues in forming conformations defining different receptor activity states (14; 15; 16; 17; 18) . Receptor phenotypes and their biological characterizations represent information about differences between the activity states (Ro to R*) (19; 20) . To improve the almost isolated consideration of point mutations for structure-function studies for the deduction of molecular activation mechanisms of GPHR we present a retrieval system for a systematic and diversified analysis of GPHR mutation data. The basic concept of our sequence-structure-function analysis is outlined in figure 1 In addition to the functional data we also included experimental conditions such as the cell system used (e.g. COS, HEK) or the type of hormone used for each experiment to enable comparison of data from the same or different experimental conditions. Additional features are the comparison of corresponding amino acids between all three GPHR sub-classes, the numbering using the three most popular numbering systems and the citation of the original study. Keywords in a 'comment' field are searchable via the 'Advanced Search', e.g. 'pathogenic mutations' (see also Supplemental Data) or mutations causing promiscuous hormone binding. This enables the identification, not just of clusters of loci generating common phenotypes, but also spatially close wild type residues that might be feasible for interaction and whose modification or disruption by mutation might therefore cause this phenotype (Supplemental Data Figure 3 ). 7
Signalling specificities and interrelated determinants of GPHRs revealed by SSFAnalysis
To quantify functional similarities and differences between wild type and mutations to distinguish between several receptor activity states the available information has to be summarized and retrieved.
In
Interacting counterpart residues constrain wild type conformation
Two examples of our work illustrate how 3D-assignment of comparable mutant phenotypes can be implemented to reveal potential interaction partners successfully.
In a previous study we suggested the importance of D633 and N676 at TSHR as interacting residues to be of general importance for all Gα subtype activations (44) . We re-analysed all presently available, well expressed transmembrane mutations of decreased Gαq and Gαs activity. Apart from the confirmation of the interacting residues, D633 and N676, by other mutations (49) finally three residues of equal phenotypes are clustered closely together and are very likely to interact with each other (see Figure 3 ).
Other experimental studies, on the pathogenic constitutive activing mutation, V509A, located in TMH3 of TSHR, confirmed A593 as an predicted interaction partner that is constraining the wild type basal active conformation (47) . The interaction partner was predicted at this time by a previous offline version of SSFA-tools, which found A593 at TMH5 to be located closely to V509 at TMH3 and that this position had already been reported as a constitutive active TSHR mutation (A593N (48) ). In summary, we have developed a system of bioinformatics tools combined with experimental, biochemical, and structural data that allows the analysis and comparison between GPHR subtypes.
This system may open new possibilities on the one hand for more focused studies and on the other hand for broad survey of GPHRs. Based on GPHR comparison under usage the SSFA resource we hypothesize, that the level of basal activity of a receptor may assist the capability for constitutive 9 activation of GPHRs caused by mutation. Furthermore, extracting common and selective CAMs and inactivating mutations for Gαs and Gαq mediated cAMP and IP accumulation revealed relevant 'hot spots', which are involved in the signalling process for one or both G-protein subtypes.
Material and Methods
Alignment -The multiple sequence alignment of human TSHR, human LHCGR, rat LHCGR, human FSHR and rat FSHR is completed by combining automatic multiple sequence alignment techniques using Clustaw (36) with a manual refinement (e.g. structural corresponding extracellular cysteines aligned to each other, no gabs allowed within the TM region according the X-ray structure of rhodopsin).
The amino acids are linked to structural features (location, structure, sub-structure). Potential Nglycosylation sites are indicated (brown), extracellular cysteines (yellow), and predicted helices (gray).
The first amino acids of leucine rich repeats (LRRs) and the amino acids that are highly conserved in the helices of GPCR class A are marked in bold.
Numbering -To achieve a unique identification of residues and a transparent navigation and within the sequence numbering we implemented the available different sequence numbering schemes according the alignment. (i) The sequence for each specific GPHR separately, including the signal peptide (Num1). Published mutagenesis data for FSHR and LHCGR given in a numbering excluding the signal peptide sequence are translated into the numbering system including the signal peptide. To facilitate analysis of the comparative relationship between the receptors, two widely spread GPCR residue indexing systems are also offered (ii) the GPCRDB numbering system and (iii) BallesterosWeinstein (Ba-We) nomenclature (25) . A highly conserved residue at each helix is used as a reference common for all GPCRs in family A. For example, the highly conserved N at TMH1 is defined as 1.50 and the highly conserved P from the NPxxY motif of TMH7 is defined as 7.50.
Structures and structural templates for GPHR models -Bovine rhodopsin, the only currently available X-ray crystal structure (40) of 7TMRs is well established as a structural template for homologous 7TMR structural models (serpentine domain and helix 8). The procedure for generating homologous serpentine domain models for human TSHR and human LHCGR and their specific differences were described elsewhere (41) . Models for rat LHCGR, human FSHR and rat FSHR were generated in the same manner. Common to all GPHRs is a large extracellular N-terminal ectodomain containing the hormone binding site in the Leucine rich repeat (LRR) domain. An X-ray crystal structure (42) of the FSHR LRR domain-FSH complex is available as a structural template for the Nterminal ectodomain excluding the hinge region. Waiving the hormone structure, this template was used for LRR models of human TSHR, human LHCGR, rat LHCGR and rat FSHR. They were generated using the same procedure as described previously for the modeling of GPHR LRR domains including Cysteine-box 1 (15) . Since the templates of the models are originally based either on the inactive rhodopsin or on the hormone bound LRR conformation and do not (and can not) represent single mutations (or even multiple mutations) conformations of different activity states (inactive, basal decreased, basal active, partial active, complete active) of the overall receptor, they are shown only as C-α atom trace representations at the wild type receptor model in our system. In our current version of the system we deliberately excluded a side chain representation to avoid on one hand false predictions of side chain interactions notably for combinations of mutations and on the other hand to avoid the impression generating conformations of respective activity states of the overall receptor, which apart from residues replacement and rotamer selection would demand much more complex modeling studies.
Database Technology -Data is stored in a MySQL database (37). The web interface was implemented using PHP (38). Additionally functions for internal database administrations have been developed, but access is restricted (for data insertion and updating). The molecular structures/models are displayed using the Jmol software (39). (table) and 3D-(Model) output. Gαs mediated signalling. In conclusion, these 3 amino acids are fundamental for both signalling pathways and 9 mutations are exclusively impair the Gαq mediated signalling capability.
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